Evidence map›Paper›PMID 38536820›Full record

ArticlePloS one2024

Changes in SARS-CoV-2 viral load and titers over time in SARS-CoV-2-infected human corpses.

Sayaka Nagasawa, Yuichiro Hirata, Sho Miyamoto, Seiya Ozono, Shun Iida, Harutaka Katano, Shigeki Tsuneya, Kei Kira, Susumu Kobayashi, Makoto Nakajima and 12 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 1 country.

Sayaka NagasawaDepartment of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.ORCID 0000-0002-0977-5043
Yuichiro HirataDepartment of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Sho MiyamotoDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Seiya OzonoDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Shun IidaDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0003-2258-9031
Harutaka KatanoDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0002-5332-4434
Shigeki TsuneyaDepartment of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kei KiraDepartment of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Susumu KobayashiDepartment of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Makoto NakajimaDepartment of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Hiroyuki AbeDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID 0000-0003-4513-1007
Masako IkemuraDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Isao YamamotoDepartment of Forensic Medicine, Kanagawa Dental University, Kanagawa, Japan.
Kimiko NakagawaDepartment of Forensic Medicine, Kanagawa Dental University, Kanagawa, Japan.
Kazumi KubotaDepartment of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan.
Shinji AkitomiJapan Medical Association Research Institute, Tokyo, Japan.
Iwao HasegawaDepartment of Forensic Medicine, Kanagawa Dental University, Kanagawa, Japan.
Tetsuo UshikuDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Tadaki SuzukiDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Hirotaro IwaseDepartment of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yohsuke MakinoDepartment of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Hisako SaitohDepartment of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
The University of Tokyo · JPChiba University · JPNational Institute of Infectious Diseases · JPKanagawa Dental University · JPTohoku University · JPTokyo Medical and Dental University · JPUniversity of Tokyo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High viral titers of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been detected in human corpses long after death. However, little is known about the kinetics of infectious SARS-CoV-2 in corpses. In this case series study, we investigated the postmortem kinetics of infectious SARS-CoV-2 in human corpses by collecting nasopharyngeal swab samples at multiple time points from six SARS-CoV-2-infected patients after their death. SARS-CoV-2 RNA was detected by quantitative reverse transcription-polymerase chain reaction from nasopharyngeal swab samples collected from all six deceased patients. A viral culture showed the presence of infectious virus in one deceased patient up to 12 days after death. Notably, this patient had a shorter time from symptom onset to death than the other patients, and autopsy samples showed pathological findings consistent with viral replication in the upper respiratory tract. Therefore, this patient died during the viral shedding phase, and the amount of infectious virus in the corpse did not decrease over time up to the date of autopsy (12 days after death). The findings of this study indicate that the persistence of SARS-CoV-2 in corpses can vary among individuals and may be associated with the stage of the disease at the time of death. These important results complement many previously reported findings on the infectivity of SARS-CoV-2 at postmortem.

Indexed as

COVID-19SARS-CoV-2CadaverHumansRNA, ViralViral LoadRNA, Viral

Identifiers

PMID38536820
PMCPMC10971691
OpenAlexW4393218838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.